PRICE T ROWE ASSOCIATES INC /MD/ - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 196 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$237
-10.9%
30,379
+10.8%
0.00%
Q2 2023$266
-6.7%
27,411
+5.7%
0.00%
Q1 2023$285
+187.9%
25,927
+12.6%
0.00%
Q4 2022$99
-99.9%
23,021
+7.3%
0.00%
Q3 2022$162,000
+25.6%
21,458
+67.7%
0.00%
Q2 2022$129,000
-97.7%
12,799
-98.3%
0.00%
-100.0%
Q1 2017$5,515,000751,3000.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders